PER
Click for more information
1.27% 8.0¢ percheron therapeutics limited

Where others have failed will Atl1102 succeed ?, page-724

  1. sken
    51 Posts.
    lightbulb Created with Sketch. 3
    clock Created with Sketch.
    16/10/21
    07:55
    Post #: 56844092
    I was thinking about this too. Perhaps Sarepta want EMA approval of the trial design before announcing (would be embarrassing to cap raise and have trial rejected)and anp need to show the ema how they intend to fund the trial to get the approval? so this would be a situation where the ema approval would be catalyst for the deal to happen. Just a theory
    ANP Price at posting: 29.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 7  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS HotCopper Highlights: Your most watched and most discussed stocks this week
right-arrow Created with Sketch.
EQN Equinox Resources reports outstanding naturally occurring antimony grade at Alturas Project
right-arrow Created with Sketch.
RMX Red Mountain Mining (ASX:RMX) announces Bonanza Grade Gold Results at Flicka Lake
right-arrow Created with Sketch.
NEWS Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive
right-arrow Created with Sketch.
NEWS Trump is President Again: What Does This Mean for Crypto?
right-arrow Created with Sketch.
NEWS Imugene kicks off Australian trial for blood cancer treatment
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢ 		Change
0.001(1.27%) 		Mkt cap ! $82.94M
Open High Low Value Volume
8.0¢ 8.3¢ 7.9¢ $461.5K 5.711M

Buyers (Bids)

No. Vol. Price($)
6 844186 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 292500 1
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.